The Combination of Remnant Cholesterol and Waist Circumference Offers Predictive Value for Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study from a Medical Examination Center

Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives

(2023) Daniel Clayton-Chubb et al.   Nutrients

Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness

(2023) Pegah Golabi et al.   Clinics in Liver Disease

Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease

(2023) Om P. Ganda   CURRENT OPINION IN LIPIDOLOGY

Waist Circumference as a Risk Factor for Non-Alcoholic Fatty Liver Disease in Older Adults in Guayaquil, Ecuador

(2023) Dayana Cabrera et al.   Geriatrics

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk

(2023) Francesco Baratta et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Associations between abdominal obesity indices and pathological features of non‐alcoholic fatty liver disease: Chinese visceral adiposity index

(2023) Ruifang Li et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis

(2023) Vikash Jaiswal et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Global epidemiology of cirrhosis — aetiology, trends and predictions

(2023) Daniel Q. Huang et al.   Nature Reviews Gastroenterology & Hepatology

Prevalence of nonalcoholic fatty liver disease and the related risk factors among healthy adults: A cross-sectional study in Chongqing, China

(2023) Lingxi Kong et al.   Frontiers in Public Health

From NAFLD to MAFLD: Definition, Pathophysiological Basis and Cardiovascular Implications

(2023) Andrea Boccatonda et al.   Biomedicines

Ophiopogonin D ameliorates non‑alcoholic fatty liver disease in high‑fat diet‑induced obese mice by improving lipid metabolism, oxidative stress and inflammatory response

(2023) Xi Huang et al.   Experimental and Therapeutic Medicine

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study

(2022) Karl Björkström et al.   LIVER INTERNATIONAL

Atherogenic index of plasma combined with waist circumference and body mass index to predict metabolic-associated fatty liver disease

(2022) Shao-Jie Duan et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study

(2021) Yang Zou et al.   Lipids in Health and Disease

Novel Application of the Traditional Lipid Ratios as Strong Risk Predictors of NASH

(2020) Mona Hegazy et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood

(2020) Aya Bardugo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

(2019) François Mach et al.   EUROPEAN HEART JOURNAL

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

(2009) Curtis K. Argo et al.   JOURNAL OF HEPATOLOGY